A detailed history of Tobam transactions in Eli Lilly & CO stock. As of the latest transaction made, Tobam holds 14,784 shares of LLY stock, worth $11.1 Million. This represents 2.39% of its overall portfolio holdings.

Number of Shares
14,784
Previous 22,172 33.32%
Holding current value
$11.1 Million
Previous $20.1 Million 34.75%
% of portfolio
2.39%
Previous 3.15%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$772.14 - $960.02 $5.7 Million - $7.09 Million
-7,388 Reduced 33.32%
14,784 $13.1 Million
Q2 2024

Jul 29, 2024

SELL
$724.87 - $909.04 $15.5 Million - $19.5 Million
-21,432 Reduced 49.15%
22,172 $20.1 Million
Q1 2024

May 02, 2024

SELL
$592.2 - $792.28 $7.88 Million - $10.5 Million
-13,302 Reduced 23.38%
43,604 $33.9 Million
Q4 2023

Jan 26, 2024

SELL
$525.19 - $619.13 $858,685 - $1.01 Million
-1,635 Reduced 2.79%
56,906 $33.2 Million
Q3 2023

Oct 31, 2023

BUY
$434.7 - $599.3 $7.95 Million - $11 Million
18,294 Added 45.45%
58,541 $31.4 Million
Q2 2023

Jul 31, 2023

SELL
$350.74 - $468.98 $8.71 Million - $11.6 Million
-24,839 Reduced 38.16%
40,247 $18.9 Million
Q1 2023

May 03, 2023

SELL
$310.63 - $364.82 $5.7 Million - $6.7 Million
-18,359 Reduced 22.0%
65,086 $22.4 Million
Q4 2022

Feb 02, 2023

SELL
$321.55 - $374.67 $2.78 Million - $3.24 Million
-8,654 Reduced 9.4%
83,445 $30.5 Million
Q3 2022

Nov 02, 2022

SELL
$296.48 - $337.87 $5.5 Million - $6.27 Million
-18,551 Reduced 16.77%
92,099 $29.8 Million
Q2 2022

Aug 02, 2022

SELL
$278.73 - $327.27 $20.5 Million - $24.1 Million
-73,636 Reduced 39.96%
110,650 $35.9 Million
Q1 2022

Apr 25, 2022

SELL
$234.69 - $291.66 $5.8 Million - $7.21 Million
-24,715 Reduced 11.83%
184,286 $52.8 Million
Q4 2021

Feb 15, 2022

SELL
$224.85 - $279.04 $6.18 Million - $7.66 Million
-27,467 Reduced 11.62%
209,001 $57.7 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $4.24 Million - $5.21 Million
19,116 Added 8.79%
236,468 $54.6 Million
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $20.6 Million - $26.7 Million
114,334 Added 110.98%
217,352 $49.9 Million
Q1 2021

May 11, 2021

BUY
$164.32 - $212.72 $16.4 Million - $21.3 Million
99,981 Added 3292.1%
103,018 $19.2 Million
Q4 2020

Feb 03, 2021

BUY
$130.46 - $172.63 $18,394 - $24,340
141 Added 4.87%
3,037 $513,000
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $423,453 - $489,800
2,896 New
2,896 $429,000
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $753,189 - $819,276
-7,053 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$110.79 - $129.32 $106,469 - $124,276
961 Added 15.77%
7,053 $781,000
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $1.19 Million - $1.4 Million
-10,651 Reduced 63.61%
6,092 $790,000
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $1.77 Million - $1.99 Million
16,743 New
16,743 $1.94 Million
Q2 2018

Aug 03, 2018

SELL
$75.7 - $86.88 $2.49 Million - $2.86 Million
-32,945 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $94,988 - $112,128
1,280 Added 4.04%
32,945 $2.55 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $275,564 - $295,574
3,363 Added 11.88%
31,665 $2.67 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $813,396 - $902,789
10,554 Added 59.47%
28,302 $2.42 Million
Q2 2017

Aug 08, 2017

BUY
N/A
17,748
17,748 $1.46 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tobam Portfolio

Follow Tobam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.